Interested in Covering Biosimilars? Here’s What You Need to Know

A Cure for Rising Drug Prices?

Biosimilars offer a cost-effective option for employers whose workers are prescribed biological medications, or biologics, for chronic and costly conditions (e.g., cancer, diabetes). But in many cases, a lack of education and access keeps employers and workers from taking advantage of the savings offered by these “biologically similar” alternatives.

This article provides context and some strategies for HR and total rewards pros to consider.